Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:1355-1361
Published online before print November 14, 2005, doi: 10.1161/01.HYP.0000192651.06674.3f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/6/1355    most recent
01.HYP.0000192651.06674.3fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, Y.
Right arrow Articles by Yang, X.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, Y.
Right arrow Articles by Yang, X.-P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*L-TYROSINE
*SODIUM CHLORIDE

(Hypertension. 2005;46:1355.)
© 2005 American Heart Association, Inc.


Original Articles

Lack of Inducible NO Synthase Reduces Oxidative Stress and Enhances Cardiac Response to Isoproterenol in Mice With Deoxycorticosterone Acetate–Salt Hypertension

Ying Sun; Oscar A. Carretero; Jiang Xu; Nour-Eddine Rhaleb; Fangfei Wang; Chunxia Lin; James J. Yang; Patrick J. Pagano; Xiao-Ping Yang

From the Hypertension and Vascular Research Division (Y.S., O.A.C., J.X., N.-E.R., F.W., C.L., P.J.P., X.-P.Y.), Department of Internal Medicine, and the Department of Biostatistics and Research Epidemiology (J.J.Y.), Henry Ford Health System and Wayne State University Detroit, Michigan.

Correspondence to Xiao-Ping Yang, MD, FAHA, Senior Staff Investigator, Hypertension and Vascular Research Division, Department of Internal Medicine, Henry Ford Health System, and Associate Professor, Wayne State University, 2799 W Grand Blvd, Detroit, MI 48202-2689. E-mail xpyang1{at}hfhs.org

Although NO derived from endothelial NO synthase (eNOS) is thought to be cardioprotective, the role of inducible NO synthase (iNOS) remains controversial. Using mice lacking iNOS (iNOS–/–), we studied (1) whether development of hypertension, cardiac hypertrophy, and dysfunction after deoxycorticosterone acetate (DOCA)–salt would be less severe compared with wild-type controls (WT; C57BL/6J), and (2) whether the cardioprotection attributable to lack of iNOS is mediated by reduced oxidative stress. Mice were uninephrectomized and received either DOCA-salt (30 mg/mouse SC and 1% NaCl+0.2% KCl in drinking water) or vehicle (tap water) for 12 weeks. Systolic blood pressure (SBP) was measured weekly. Left ventricular (LV) ejection fraction (EF) by echocardiography and cardiac response to isoproterenol (50 ng/mouse IV) were studied at the end of the experiment. Expression of eNOS and iNOS as well as the oxidative stress markers 4-hydroxy-2-nonenal (4-HNE, a marker of lipid peroxidation) and nitrotyrosine (a marker for peroxynitrite) were determined by Western blot and immunohistochemical staining, respectively. DOCA-salt increased SBP and LV weight similarly in both strains and decreased EF in WT but not in iNOS–/–. Cardiac contractile and relaxation responses to isoproterenol were greater, 4-HNE and nitrotyrosine levels were lower, and eNOS expression tended to be higher in iNOS–/–. We conclude that lack of iNOS leads to better preservation of cardiac function, which may be mediated by reduced oxidative stress and increased eNOS; however, it does not seem to play a significant role in preventing DOCA-salt–induced hypertension and hypertrophy.


Key Words: nitric oxide synthase • cardiac function • oxidative stress




This article has been cited by other articles:


Home page
Circ. Res.Home page
V. Rudolph and B. A. Freeman
Cardiovascular Consequences When Nitric Oxide and Lipid Signaling Converge
Circ. Res., September 11, 2009; 105(6): 511 - 522.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Sun, O. A. Carretero, J. Xu, N.-E. Rhaleb, J. J. Yang, P. J. Pagano, and X.-P. Yang
Deletion of Inducible Nitric Oxide Synthase Provides Cardioprotection in Mice With 2-Kidney, 1-Clip Hypertension
Hypertension, January 1, 2009; 53(1): 49 - 56.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
J. Zhang, A. Knapton, S. E. Lipshultz, J. L. Weaver, and E. H. Herman
Isoproterenol-induced Cardiotoxicity in Sprague-Dawley Rats: Correlation of Reversible and Irreversible Myocardial Injury with Release of Cardiac Troponin T and Roles of iNOS in Myocardial Injury
Toxicol Pathol, February 1, 2008; 36(2): 277 - 278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Juric, P. Wojciechowski, D. K. Das, and T. Netticadan
Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2138 - H2143.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
X. Liao, J.-M. Liu, L. Du, A. Tang, Y. Shang, S. Q. Wang, L.-Y. Chen, and Q. Chen
Nitric oxide signaling in stretch-induced apoptosis of neonatal rat cardiomyocytes
FASEB J, September 1, 2006; 20(11): 1883 - 1885.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
R. Hataishi, A. C. Rodrigues, J. G. Morgan, F. Ichinose, G. Derumeaux, K. D. Bloch, M. H. Picard, and M. Scherrer-Crosbie
Nitric oxide synthase 2 and pressure-overload-induced left ventricular remodelling in mice
Exp Physiol, May 1, 2006; 91(3): 633 - 639.
[Abstract] [Full Text] [PDF]